• 147184 Citations
  • 179 h-Index
1981 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 40 Similar Profiles
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Precursor Cell Lymphoblastic Leukemia-Lymphoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Leukemia, Myeloid, Chronic Phase Medicine & Life Sciences
Philadelphia Chromosome Medicine & Life Sciences
Leukemia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1981 2019

1 Citation (Scopus)

An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 study

Savona, M. R., Odenike, O., Amrein, P. C., Steensma, D. P., DeZern, A. E., Michaelis, L. C., Faderl, S., Harb, W., Kantarjian, H. M., Lowder, J., Oganesian, A., Azab, M. & Garcia-Manero, G., Apr 1 2019, In : The Lancet Haematology. 6, 4, p. e194-e203

Research output: Contribution to journalArticle

decitabine
Myelodysplastic Syndromes
Area Under Curve
Cytidine Deaminase
Leukemia, Myelomonocytic, Chronic
Myelodysplastic Syndromes
Diploidy
Cytogenetics
Survival

BETP degradation simultaneously targets acute myelogenous leukemic stem cells and the microenvironment

Piya, S., Mu, H., Bhattacharya, S., Lorenzi, P. L., Davis, R. E., McQueen, T., Ruvolo, V., Baran, N., Wang, Z., Qian, Y., Crews, C. M., Konopleva, M., Ishizawa, J., James You, M., Kantarjian, H. M., Andreeff, M. & Borthakur, G., May 1 2019, In : Journal of Clinical Investigation. 129, 5, p. 1878-1894 17 p.

Research output: Contribution to journalArticle

Open Access
Stem Cell Niche
Proteolysis
Down-Regulation
Acute Myeloid Leukemia
Stem Cells

Blinatumomab for the treatment of acute lymphoblastic leukemia: an update

Rausch, C. R., Paul, S., Nasnas, P. E., Kantarjian, H. M. & Jabbour, E. J., Feb 1 2019, In : Expert Opinion on Orphan Drugs. 7, 2, p. 41-46 6 p.

Research output: Contribution to journalArticle

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Philadelphia Chromosome
Therapeutics
Phase III Clinical Trials
Expert Testimony

Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemia

Dombret, H., Topp, M. S., Schuh, A. C., Wei, A. H., Durrant, S., Bacon, C. L., Tran, Q., Zimmerman, Z. & Kantarjian, H. M., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

B-Lymphoid Precursor Cells
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Drug Therapy
Hematopoietic Stem Cell Transplantation
Chromosomes, Human, 4-5